Modulation 2129161 ? O
of ? ? O
rat ? ? O
salivary ? ? O
carbonic ? ? I-gene
anhydrase ? ? I-gene
by ? ? O
pilocarpine ? ? I-treatment
. ? ? O

Carbonic 2129161 ? I-gene
anhydrase ? ? I-gene
( ? ? O
CA ? ? I-gene
) ? ? O
from ? ? O
pilocarpine-treated ? ? I-treatment
( ? ? O
1.5 ? ? O
mg ? ? O
/ ? ? O
kg ? ? O
body ? ? O
weight ? ? O
; ? ? O
i.p ? ? O
. ? ? O
) ? ? O

rat 2129161 ? O
saliva ? ? O
was ? ? O
purified ? ? O
by ? ? O
inhibitor ? ? O
affinity ? ? O
chromatography ? ? O
. ? ? O

The 2129161 ? O
purified ? ? O
CA ? ? I-gene
contained ? ? O
Mr ? ? I-gene
42000 ? ? I-gene
and ? ? O
39000 ? ? I-gene
proteins ? ? O
on ? ? O
sodium ? ? O
dodecyl ? ? O
sulfate ? ? O
polyacrylamide ? ? O
gel ? ? O
electrophoresis ? ? O
. ? ? O

In 2129161 ? O
addition ? ? O
to ? ? O
the ? ? O
erythrocyte ? ? I-gene
isozyme ? ? I-gene
( ? ? O
Mr ? ? I-gene
30000 ? ? I-gene
) ? ? O
, ? ? O
salivary ? ? O
gland ? ? O
CA ? ? I-gene
from ? ? O
rats ? ? O
without ? ? O
pilocarpine ? ? I-treatment
stimulation ? ? O
contained ? ? O
Mr ? ? I-gene
39000 ? ? I-gene
and ? ? O
33000 ? ? I-gene
proteins ? ? O
and ? ? O
that ? ? O
from ? ? O
rats ? ? O
with ? ? O
pilocarpine ? ? I-treatment
stimulation ? ? O
also ? ? O
contained ? ? O
Mr ? ? I-gene
42000 ? ? I-gene
protein ? ? O
. ? ? O

The 2129161 ? O
42000Da ? ? I-gene
and ? ? O
39000Da ? ? I-gene
proteins ? ? O
bound ? ? O
to ? ? O
concanavalin ? ? O
A ? ? O
and ? ? O
were ? ? O
cleaved ? ? O
by ? ? O
endo-beta-N-acetylglucosaminidase ? ? I-gene
F ? ? I-gene
to ? ? O
become ? ? O
39000Da ? ? I-gene
and ? ? O
33000Da ? ? I-gene
proteins ? ? O
. ? ? O

These 2129161 ? O
results ? ? O
suggest ? ? O
that ? ? O
, ? ? O
under ? ? O
the ? ? O
influence ? ? O
of ? ? O
pilocarpine ? ? I-treatment
, ? ? O
salivary ? ? O
gland ? ? O
cells ? ? O
synthesize ? ? O
a ? ? O
new ? ? O
glycoprotein ? ? I-gene
, ? ? O
Mr ? ? I-gene
42000 ? ? I-gene
, ? ? O
via ? ? O
N-linked ? ? O
glycosylation ? ? O
of ? ? O
a ? ? O
39000Da ? ? I-gene
glycoprotein ? ? I-gene
, ? ? O
which ? ? O
is ? ? O
the ? ? O
only ? ? O
secretory ? ? I-gene
glycoprotein ? ? I-gene
in ? ? O
the ? ? O
unstimulated ? ? O
salivary ? ? O
gland ? ? O
and ? ? O
is ? ? O
produced ? ? O
by ? ? O
N-linked ? ? O
glycosylation ? ? O
of ? ? O
a ? ? O
33000Da ? ? I-gene
polypeptide ? ? O
. ? ? O

Control 2361193 ? O
of ? ? O
intraocular ? ? O
pressure ? ? O
after ? ? O
cataract ? ? I-disease
extraction ? ? O
. ? ? O

We 2361193 ? O
carried ? ? O
out ? ? O
a ? ? O
prospective ? ? O
randomized ? ? O
study ? ? O
in ? ? O
172 ? ? O
patients ? ? O
undergoing ? ? O
cataract ? ? I-treatment
extraction ? ? I-treatment
and ? ? O
lens ? ? I-treatment
implantation ? ? I-treatment
to ? ? O
compare ? ? O
the ? ? O
effects ? ? O
of ? ? O
pilocarpine ? ? I-treatment
gel ? ? O
, ? ? O
1 ? ? O
% ? ? O
acetylcholine ? ? I-treatment
chloride ? ? I-treatment
and ? ? O
0.01 ? ? O
% ? ? O
carbachol ? ? I-treatment
on ? ? O
early ? ? O
postoperative ? ? I-disease
intraocular ? ? I-disease
pressure ? ? I-disease
( ? ? O
IOP ? ? I-disease
) ? ? O
, ? ? O
to ? ? O
determine ? ? O
the ? ? O
effect ? ? O
of ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
on ? ? O
IOP ? ? I-disease
and ? ? O
to ? ? O
compare ? ? O
the ? ? O
effects ? ? O
of ? ? O
0.01 ? ? O
% ? ? O
carbachol ? ? I-treatment
( ? ? O
full-strength ? ? O
) ? ? O
and ? ? O
0.005 ? ? O
% ? ? O
carbachol ? ? I-treatment
( ? ? O
half-strength ? ? O
) ? ? O
on ? ? O
IOP ? ? I-disease
, ? ? O
pupil ? ? I-disease
size ? ? I-disease
and ? ? O
brow ? ? I-disease
ache ? ? I-disease
. ? ? O

IOP 2361193 ? I-disease
was ? ? O
measured ? ? O
3 ? ? O
, ? ? O
6 ? ? O
, ? ? O
9 ? ? O
and ? ? O
24 ? ? O
hours ? ? O
after ? ? O
surgery ? ? O
, ? ? O
and ? ? O
in ? ? O
the ? ? O
full- ? ? O
and ? ? O
half-strength ? ? O
carbachol ? ? I-treatment
groups ? ? O
pupil ? ? I-disease
size ? ? I-disease
and ? ? O
subjective ? ? O
complaints ? ? O
of ? ? O
brow ? ? I-disease
ache ? ? I-disease
were ? ? O
recorded ? ? O
. ? ? O

The 2361193 ? O
mean ? ? O
IOP ? ? I-disease
3 ? ? O
and ? ? O
6 ? ? O
hours ? ? O
after ? ? O
surgery ? ? O
was ? ? O
significantly ? ? O
lower ? ? O
in ? ? O
all ? ? O
the ? ? O
treatment ? ? O
groups ? ? O
than ? ? O
in ? ? O
the ? ? O
control ? ? O
groups ? ? O
. ? ? O

At 2361193 ? O
9 ? ? O
and ? ? O
24 ? ? O
hours ? ? O
it ? ? O
was ? ? O
significantly ? ? O
lower ? ? O
only ? ? O
in ? ? O
the ? ? O
carbachol ? ? I-treatment
groups ? ? O
. ? ? O

The 2361193 ? O
use ? ? O
of ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
was ? ? O
not ? ? O
found ? ? O
to ? ? O
affect ? ? O
the ? ? O
postoperative ? ? O
IOP ? ? I-disease
. ? ? O

There 2361193 ? O
was ? ? O
no ? ? O
difference ? ? O
in ? ? O
postoperative ? ? O
IOP ? ? I-disease
or ? ? O
miosis ? ? I-disease
between ? ? O
the ? ? O
full- ? ? O
and ? ? O
half-strength ? ? O
carbachol ? ? I-treatment
groups ? ? O
, ? ? O
but ? ? O
fewer ? ? O
patients ? ? O
in ? ? O
the ? ? O
half-strength ? ? O
group ? ? O
than ? ? O
in ? ? O
the ? ? O
full-strength ? ? O
group ? ? O
reported ? ? O
brow ? ? I-disease
ache ? ? I-disease
at ? ? O
9 ? ? O
and ? ? O
24 ? ? O
hours ? ? O
. ? ? O

The 2361193 ? O
results ? ? O
suggest ? ? O
that ? ? O
carbachol ? ? I-treatment
is ? ? O
the ? ? O
most ? ? O
effective ? ? O
agent ? ? O
currently ? ? O
available ? ? O
for ? ? O
the ? ? O
management ? ? O
of ? ? O
IOP ? ? I-disease
after ? ? O
cataract ? ? I-disease
extraction ? ? O
. ? ? O

Sodium 2743795 ? I-treatment
hyaluronate ? ? I-treatment
as ? ? O
an ? ? O
ophthalmic ? ? O
vehicle ? ? O
: ? ? O
some ? ? O
factors ? ? O
governing ? ? O
its ? ? O
effect ? ? O
on ? ? O
the ? ? O
ocular ? ? O
absorption ? ? O
of ? ? O
pilocarpine ? ? I-treatment
. ? ? O

Sodium 2743795 ? I-treatment
hyaluronate ? ? I-treatment
, ? ? O
as ? ? O
an ? ? O
additive ? ? O
to ? ? O
aqueous ? ? O
ophthalmic ? ? O
formulations ? ? O
, ? ? O
has ? ? O
been ? ? O
claimed ? ? O
to ? ? O
increase ? ? O
the ? ? O
ocular ? ? O
contact ? ? O
time ? ? O
and ? ? O
, ? ? O
thereby ? ? O
, ? ? O
the ? ? O
drug ? ? O
bioavailability ? ? O
. ? ? O

In 2743795 ? O
the ? ? O
present ? ? O
study ? ? O
, ? ? O
the ? ? O
effect ? ? O
of ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
on ? ? O
corneal ? ? O
residence ? ? O
time ? ? O
and ? ? O
drug ? ? O
absorption ? ? O
in ? ? O
rabbits ? ? O
was ? ? O
investigated ? ? O
. ? ? O

Addition 2743795 ? O
of ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
( ? ? O
0.125 ? ? O
% ? ? O
) ? ? O
to ? ? O
a ? ? O
3H-pilocarpine ? ? I-treatment
HCl ? ? I-treatment
solution ? ? O
resulted ? ? O
in ? ? O
increased ? ? O
retention ? ? O
of ? ? O
radioactivity ? ? O
in ? ? O
tear ? ? O
fluid ? ? O
and ? ? O
a ? ? O
2-fold ? ? O
increase ? ? O
in ? ? O
drug ? ? O
concentration ? ? O
in ? ? O
the ? ? O
cornea ? ? O
and ? ? O
aqueous ? ? O
humor ? ? O
. ? ? O

Further 2743795 ? O
, ? ? O
the ? ? O
effects ? ? O
of ? ? O
concentration ? ? O
and ? ? O
molecular ? ? O
weight ? ? O
of ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
on ? ? O
the ? ? O
miosis ? ? I-disease
induced ? ? O
by ? ? O
pilocarpine ? ? I-treatment
in ? ? O
rabbits ? ? O
were ? ? O
studied ? ? O
. ? ? O

A 2743795 ? O
significant ? ? O
increase ? ? O
of ? ? O
miotic ? ? I-disease
response ? ? I-disease
was ? ? O
seen ? ? O
at ? ? O
concentrations ? ? O
just ? ? O
less ? ? O
than ? ? O
0.1 ? ? O
% ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
. ? ? O

Pilocarpine 2743795 ? I-treatment
solutions ? ? O
prepared ? ? O
from ? ? O
high ? ? O
mol.wt ? ? O
. ? ? O

sodium 2743795 ? I-treatment
hyaluronate ? ? I-treatment
exhibited ? ? O
a ? ? O
greater ? ? O
miotic ? ? I-disease
response ? ? I-disease
than ? ? O
those ? ? O
prepared ? ? O
from ? ? O
lower ? ? O
mol.wt ? ? O
. ? ? O

samples 2743795 ? O
. ? ? O

This 2743795 ? O
might ? ? O
indicate ? ? O
that ? ? O
other ? ? O
physicochemical ? ? O
properties ? ? O
of ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
influence ? ? O
drug ? ? O
bioavailability ? ? O
. ? ? O

Electrolyte 2776293 ? O
composition ? ? O
of ? ? O
lacrimal ? ? O
gland ? ? O
fluid ? ? O
and ? ? O
tears ? ? O
of ? ? O
normal ? ? O
and ? ? O
vitamin ? ? I-disease
A-deficient ? ? I-disease
rabbits ? ? O
. ? ? O

Rabbit 2776293 ? O
tears ? ? O
and ? ? O
lacrimal ? ? O
gland ? ? O
fluid ? ? O
were ? ? O
collected ? ? O
simultaneously ? ? O
during ? ? O
pilocarpine ? ? I-treatment
stimulation ? ? O
with ? ? O
the ? ? O
goal ? ? O
of ? ? O
comparing ? ? O
the ? ? O
ionic ? ? O
composition ? ? O
of ? ? O
these ? ? O
fluids ? ? O
at ? ? O
various ? ? O
flow ? ? O
rates ? ? O
. ? ? O

Ions 2776293 ? O
measured ? ? O
were ? ? O
sodium ? ? I-treatment
, ? ? O
potassium ? ? I-treatment
, ? ? O
calcium ? ? I-treatment
, ? ? O
magnesium ? ? I-treatment
, ? ? O
zinc ? ? I-treatment
, ? ? O
chloride ? ? I-treatment
, ? ? O
and ? ? O
bicarbonate ? ? I-treatment
. ? ? O

Human 2776293 ? O
tears ? ? O
were ? ? O
also ? ? O
analyzed ? ? O
for ? ? O
purposes ? ? O
of ? ? O
comparison ? ? O
. ? ? O

Generally 2776293 ? O
, ? ? O
tears ? ? O
and ? ? O
lacrimal ? ? O
gland ? ? O
fluid ? ? O
do ? ? O
not ? ? O
differ ? ? O
in ? ? O
ionic ? ? O
composition ? ? O
except ? ? O
for ? ? O
zinc ? ? I-treatment
and ? ? O
bicarbonate ? ? I-treatment
, ? ? O
which ? ? O
are ? ? O
in ? ? O
higher ? ? O
concentration ? ? O
in ? ? O
tears ? ? O
than ? ? O
in ? ? O
lacrimal ? ? O
gland ? ? O
fluid ? ? O
. ? ? O

The 2776293 ? O
ionic ? ? O
composition ? ? O
of ? ? O
tears ? ? O
and ? ? O
lacrimal ? ? O
gland ? ? O
fluid ? ? O
of ? ? O
vitamin ? ? I-disease
A-deficient ? ? I-disease
rabbits ? ? O
was ? ? O
also ? ? O
analyzed ? ? O
. ? ? O

The 2776293 ? O
maximal ? ? O
flow ? ? O
rate ? ? O
of ? ? O
lacrimal ? ? O
gland ? ? O
fluid ? ? O
was ? ? O
decreased ? ? O
in ? ? O
vitamin ? ? I-disease
A-deficient ? ? I-disease
rabbits ? ? O
as ? ? O
were ? ? O
calcium ? ? I-treatment
levels ? ? O
in ? ? O
tears ? ? O
and ? ? O
lacrimal ? ? O
gland ? ? O
fluid ? ? O
, ? ? O
as ? ? O
compared ? ? O
with ? ? O
controls ? ? O
. ? ? O

Concentrations 2776293 ? O
of ? ? O
other ? ? O
ions ? ? O
generally ? ? O
did ? ? O
not ? ? O
differ ? ? O
from ? ? O
normal ? ? O
levels ? ? O
, ? ? O
indicating ? ? O
that ? ? O
vitamin ? ? I-disease
A ? ? I-disease
deficiency ? ? I-disease
has ? ? O
only ? ? O
moderate ? ? O
effects ? ? O
on ? ? O
lacrimal ? ? O
gland ? ? O
function ? ? O
in ? ? O
the ? ? O
rabbit ? ? O
. ? ? O

Drug 2916980 ? O
binding ? ? O
of ? ? O
ophthalmic ? ? I-treatment
viscoelastic ? ? I-treatment
agents ? ? I-treatment
. ? ? O

When 2916980 ? O
viscoelastic ? ? I-treatment
agents ? ? I-treatment
that ? ? O
contain ? ? O
hyaluronate ? ? I-treatment
sodium ? ? I-treatment
are ? ? O
used ? ? O
during ? ? O
anterior ? ? O
segment ? ? O
surgical ? ? O
procedures ? ? O
, ? ? O
it ? ? O
is ? ? O
common ? ? O
for ? ? O
some ? ? O
of ? ? O
the ? ? O
material ? ? O
to ? ? O
remain ? ? O
intraocularly ? ? O
after ? ? O
the ? ? O
surgery ? ? I-treatment
is ? ? O
completed ? ? O
. ? ? O

A 2916980 ? O
variety ? ? O
of ? ? O
drugs ? ? O
, ? ? O
used ? ? O
intracamerally ? ? O
or ? ? O
topically ? ? O
following ? ? O
surgery ? ? I-treatment
, ? ? O
are ? ? O
also ? ? O
present ? ? O
. ? ? O

These 2916980 ? O
drugs ? ? O
may ? ? O
be ? ? O
bound ? ? O
to ? ? O
the ? ? O
polyanionic ? ? I-treatment
hyaluronate ? ? I-treatment
molecule ? ? I-treatment
. ? ? O

This 2916980 ? O
occurrence ? ? O
may ? ? O
cause ? ? O
drug ? ? O
alterations ? ? O
in ? ? O
therapeutic ? ? O
effectiveness ? ? O
, ? ? O
pharmacokinetics ? ? O
, ? ? O
and ? ? O
toxicity ? ? I-disease
. ? ? O

To 2916980 ? O
investigate ? ? O
the ? ? O
possibility ? ? O
for ? ? O
drug-viscoelastic ? ? O
agent ? ? O
adsorption ? ? O
, ? ? O
in ? ? O
vitro ? ? O
drug-binding ? ? O
studies ? ? O
were ? ? O
performed ? ? O
on ? ? O
three ? ? O
commercial ? ? O
viscoelastic ? ? I-treatment
agents ? ? I-treatment
; ? ? O
undiluted ? ? O
aliquots ? ? O
of ? ? O
Amvisc ? ? I-treatment
, ? ? O
Healon ? ? I-treatment
, ? ? O
or ? ? O
Viscoat ? ? I-treatment
were ? ? O
mixed ? ? O
with ? ? O
radiolabeled ? ? O
D-threo-chloramphenicol ? ? I-treatment
, ? ? O
dexamethasone ? ? I-treatment
, ? ? O
L-epinephrine ? ? I-treatment
, ? ? O
or ? ? O
pilocarpine ? ? I-treatment
hydrochloride ? ? I-treatment
, ? ? O
placed ? ? O
in ? ? O
dialysis ? ? O
membranes ? ? O
, ? ? O
and ? ? O
dialyzed ? ? O
for ? ? O
24 ? ? O
hours ? ? O
against ? ? O
an ? ? O
isotonic ? ? O
phosphate ? ? O
buffer ? ? O
. ? ? O

The 2916980 ? O
calculated ? ? O
drug ? ? O
binding ? ? O
by ? ? O
a ? ? O
viscoelastic ? ? I-treatment
agent ? ? I-treatment
ranged ? ? O
from ? ? O
0 ? ? O
% ? ? O
to ? ? O
1.5 ? ? O
% ? ? O
. ? ? O

These 2916980 ? O
extremely ? ? O
low ? ? O
values ? ? O
for ? ? O
in ? ? O
vitro ? ? O
drug ? ? O
uptake ? ? O
by ? ? O
viscoelastic ? ? I-treatment
agents ? ? I-treatment
made ? ? O
it ? ? O
unlikely ? ? O
that ? ? O
any ? ? O
significant ? ? O
drug-viscoelastic ? ? O
agent ? ? O
interaction ? ? O
would ? ? O
occur ? ? O
in ? ? O
the ? ? O
postoperative ? ? O
eye ? ? O
. ? ? O

Tear 3170794 ? O
secretion ? ? O
and ? ? O
lacrimal ? ? O
gland ? ? O
function ? ? O
of ? ? O
rabbits ? ? O
treated ? ? O
with ? ? O
isotretinoin ? ? I-treatment
. ? ? O

Adverse 3170794 ? I-disease
ocular ? ? I-disease
reactions ? ? I-disease
including ? ? O
dry ? ? I-disease
eye ? ? I-disease
symptoms ? ? I-disease
and ? ? O
blepharoconjunctivitis ? ? I-disease
are ? ? O
common ? ? O
side ? ? O
effects ? ? O
of ? ? O
treatment ? ? O
with ? ? O
isotretinoin ? ? I-treatment
( ? ? O
13-cis-retinoic ? ? I-treatment
acid ? ? I-treatment
) ? ? O
. ? ? O

However 3170794 ? O
, ? ? O
there ? ? O
is ? ? O
little ? ? O
agreement ? ? O
in ? ? O
the ? ? O
literature ? ? O
on ? ? O
the ? ? O
effect ? ? O
of ? ? O
this ? ? O
drug ? ? O
on ? ? O
the ? ? O
tears ? ? O
. ? ? O

Because 3170794 ? O
we ? ? O
have ? ? O
previously ? ? O
shown ? ? O
that ? ? O
the ? ? O
lacrimal ? ? O
gland ? ? O
secretes ? ? O
isotretinoin ? ? I-treatment
, ? ? O
we ? ? O
conducted ? ? O
a ? ? O
study ? ? O
of ? ? O
the ? ? O
effect ? ? O
of ? ? O
isotretinoin ? ? I-treatment
on ? ? O
lacrimal ? ? O
gland ? ? O
function ? ? O
. ? ? O

Rabbits 3170794 ? O
were ? ? O
treated ? ? O
with ? ? O
isotretinoin ? ? I-treatment
for ? ? O
5 ? ? O
months ? ? O
. ? ? O

Throughout 3170794 ? O
the ? ? O
study ? ? O
tear ? ? O
secretion ? ? O
was ? ? O
monitored ? ? O
by ? ? O
the ? ? O
Schirmer ? ? O
test ? ? O
. ? ? O

At 3170794 ? O
the ? ? O
end ? ? O
of ? ? O
the ? ? O
study ? ? O
lacrimal ? ? O
gland ? ? O
function ? ? O
was ? ? O
assessed ? ? O
by ? ? O
measurement ? ? O
of ? ? O
fluid ? ? O
and ? ? O
protein ? ? O
secretion ? ? O
rates ? ? O
and ? ? O
secretion ? ? O
of ? ? O
retinol ? ? I-treatment
in ? ? O
response ? ? O
to ? ? O
a ? ? O
pilocarpine ? ? I-treatment
stimulus ? ? O
. ? ? O

Lacrimal 3170794 ? O
gland ? ? O
function ? ? O
was ? ? O
not ? ? O
affected ? ? O
by ? ? O
isotretinoin ? ? I-treatment
as ? ? O
compared ? ? O
with ? ? O
a ? ? O
group ? ? O
of ? ? O
age-matched ? ? O
control ? ? O
rabbits ? ? O
; ? ? O
however ? ? O
, ? ? O
Schirmer ? ? O
test ? ? O
scores ? ? O
were ? ? O
significantly ? ? O
increased ? ? O
in ? ? O
the ? ? O
treated ? ? O
animals ? ? O
as ? ? O
compared ? ? O
with ? ? O
control ? ? O
values ? ? O
. ? ? O

We 3170794 ? O
conclude ? ? O
that ? ? O
isotretinoin ? ? I-treatment
is ? ? O
not ? ? O
toxic ? ? O
to ? ? O
the ? ? O
lacrimal ? ? O
gland ? ? O
of ? ? O
rabbits ? ? O
. ? ? O

This 3170794 ? O
suggests ? ? O
that ? ? O
ocular ? ? I-disease
irritation ? ? I-disease
in ? ? O
patients ? ? O
treated ? ? O
with ? ? O
isotretinoin ? ? I-treatment
is ? ? O
not ? ? O
caused ? ? O
by ? ? O
decreased ? ? I-disease
tear ? ? I-disease
secretion ? ? I-disease
during ? ? O
therapy ? ? O
. ? ? O

Respiratory 5068007 ? O
responses ? ? O
to ? ? O
chemical ? ? O
pulses ? ? O
in ? ? O
the ? ? O
cerebrospinal ? ? O
fluid ? ? O
of ? ? O
cats ? ? O
. ? ? O

1 5068007 ? O
. ? ? O

In 5068007 ? O
cats ? ? O
anaesthetized ? ? O
with ? ? O
pentobarbitone ? ? I-treatment
, ? ? O
the ? ? O
fluid ? ? O
spaces ? ? O
in ? ? O
and ? ? O
around ? ? O
the ? ? O
brain ? ? O
stem ? ? O
were ? ? O
perfused ? ? O
from ? ? O
the ? ? O
third ? ? O
ventricle ? ? O
to ? ? O
the ? ? O
foramen ? ? O
magnum ? ? O
with ? ? O
artificial ? ? I-treatment
cerebrospinal ? ? I-treatment
fluid ? ? I-treatment
( ? ? O
c.s.f ? ? I-treatment
. ? ? O
) ? ? O

flowing 5068007 ? O
usually ? ? O
at ? ? O
the ? ? O
rate ? ? O
of ? ? O
5 ? ? O
ml ? ? O
/ ? ? O
minute ? ? O
. ? ? O

Test 5068007 ? O
solutions ? ? O
were ? ? O
substituted ? ? O
for ? ? O
the ? ? O
artificial ? ? I-treatment
c.s.f ? ? I-treatment
. ? ? O

without 5068007 ? O
switching ? ? O
artifact ? ? O
for ? ? O
periods ? ? O
varying ? ? O
from ? ? O
5 ? ? O
to ? ? O
60 ? ? O
seconds ? ? O
. ? ? O

Observations 5068007 ? O
were ? ? O
made ? ? O
on ? ? O
respiratory ? ? O
excursions ? ? O
, ? ? O
end-expiratory ? ? O
% ? ? O
CO ? ? O
( ? ? O
2 ? ? O
) ? ? O
and ? ? O
arterial ? ? O
blood ? ? O
pressure.2 ? ? O
. ? ? O

Perfusion 5068007 ? O
with ? ? O
sucrose ? ? I-treatment
solution ? ? O
equiosmolar ? ? O
with ? ? O
the ? ? O
c.s.f ? ? I-treatment
. ? ? O

produced 5068007 ? O
no ? ? O
respiratory ? ? O
or ? ? O
cardiovascular ? ? O
response ? ? O
. ? ? O

Replacement 5068007 ? O
of ? ? O
sodium ? ? O
with ? ? O
potassium ? ? I-treatment
( ? ? O
60 ? ? O
to ? ? O
133 ? ? O
mM ? ? O
) ? ? O
resulted ? ? O
in ? ? O
a ? ? O
prompt ? ? O
but ? ? O
mild ? ? I-disease
respiratory ? ? I-disease
stimulation ? ? I-disease
and ? ? O
a ? ? O
delayed ? ? I-disease
fall ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure ? ? I-disease
associated ? ? O
with ? ? O
a ? ? O
slowing ? ? I-disease
of ? ? I-disease
the ? ? I-disease
heart ? ? I-disease
beat ? ? I-disease
. ? ? O

Replacement 5068007 ? O
of ? ? O
sodium ? ? O
with ? ? O
magnesium ? ? I-treatment
( ? ? O
40 ? ? O
to ? ? O
131 ? ? O
mM ? ? O
) ? ? O
resulted ? ? O
in ? ? O
a ? ? O
late ? ? I-disease
prolonged ? ? I-disease
apneustic ? ? I-disease
depression ? ? I-disease
of ? ? I-disease
breathing ? ? I-disease
and ? ? O
in ? ? O
an ? ? O
early ? ? O
but ? ? O
slight ? ? I-disease
reduction ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure.3 ? ? I-disease
. ? ? O

Procaine 5068007 ? I-treatment
( ? ? O
1 ? ? O
to ? ? O
50 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
elicited ? ? O
a ? ? O
respiratory ? ? O
response ? ? O
similar ? ? O
to ? ? O
that ? ? O
of ? ? O
excess ? ? O
magnesium ? ? I-treatment
; ? ? O
however ? ? O
, ? ? O
an ? ? O
initial ? ? I-disease
rise ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure ? ? I-disease
to ? ? O
as ? ? O
high ? ? O
as ? ? O
200 ? ? O
mmHg ? ? O
was ? ? O
evoked ? ? O
with ? ? O
procaine ? ? I-treatment
. ? ? O

Nicotine 5068007 ? I-treatment
( ? ? O
0.05 ? ? O
to ? ? O
0.5 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
produced ? ? O
an ? ? O
immediate ? ? I-disease
brief ? ? I-disease
bradypnea ? ? I-disease
followed ? ? O
by ? ? O
a ? ? O
vigorous ? ? I-disease
and ? ? I-disease
slowly ? ? I-disease
reversing ? ? I-disease
hyperpnea ? ? I-disease
accompanied ? ? O
most ? ? O
often ? ? O
by ? ? O
a ? ? O
fall ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure ? ? I-disease
. ? ? O

Tachyphylaxis 5068007 ? I-disease
was ? ? O
observed ? ? O
in ? ? O
the ? ? O
response ? ? O
to ? ? O
nicotine ? ? I-treatment
. ? ? O

Noradrenaline 5068007 ? I-treatment
( ? ? O
0.001 ? ? O
and ? ? O
0.1 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
did ? ? O
not ? ? O
produce ? ? O
any ? ? O
effect ? ? O
, ? ? O
and ? ? O
it ? ? O
did ? ? O
not ? ? O
alter ? ? O
the ? ? O
responses ? ? O
elicited ? ? O
by ? ? O
procaine ? ? I-treatment
and ? ? O
nicotine ? ? I-treatment
given ? ? O
by ? ? O
perfusion ? ? O
either ? ? O
simultaneous ? ? O
with ? ? O
or ? ? O
subsequent ? ? O
to ? ? O
the ? ? O
noradrenaline ? ? I-treatment
. ? ? O

Acetylcholine 5068007 ? I-treatment
( ? ? O
0.5 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
produced ? ? O
weak ? ? I-disease
transient ? ? I-disease
respiratory ? ? I-disease
stimulation ? ? I-disease
and ? ? O
a ? ? O
small ? ? I-disease
fluctuation ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure ? ? I-disease
which ? ? O
disappeared ? ? O
in ? ? O
repeated ? ? O
tests ? ? O
. ? ? O

Methacholine 5068007 ? I-treatment
( ? ? O
1 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
caused ? ? O
a ? ? O
brief ? ? I-disease
hyperpnea ? ? I-disease
and ? ? O
a ? ? O
fall ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure ? ? I-disease
both ? ? O
of ? ? O
which ? ? O
were ? ? O
abolished ? ? O
after ? ? O
atropine ? ? I-treatment
( ? ? O
0.2 ? ? O
mg ? ? O
) ? ? O
was ? ? O
injected ? ? O
into ? ? O
the ? ? O
third ? ? O
ventricle ? ? O
. ? ? O

Pilocarpine 5068007 ? I-treatment
( ? ? O
10 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
elicited ? ? O
no ? ? O
change ? ? O
in ? ? O
respiration ? ? O
or ? ? O
blood ? ? O
pressure ? ? O
. ? ? O

Respiratory 5068007 ? I-disease
and ? ? I-disease
cardiovascular ? ? I-disease
effects ? ? I-disease
produced ? ? O
by ? ? O
strychnine ? ? I-treatment
( ? ? O
1 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
were ? ? O
attributable ? ? O
non-specifically ? ? O
to ? ? O
convulsive ? ? I-disease
movements ? ? I-disease
of ? ? O
the ? ? O
animal ? ? O
. ? ? O

Ethamivan 5068007 ? I-treatment
( ? ? O
1 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
produced ? ? O
a ? ? O
single ? ? I-disease
deep ? ? I-disease
breath ? ? I-disease
and ? ? O
a ? ? O
slowly ? ? I-disease
reversing ? ? I-disease
rise ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure ? ? I-disease
. ? ? O

Cyanide 5068007 ? I-treatment
( ? ? O
0.5 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
barely ? ? O
stimulated ? ? O
the ? ? O
respiration ? ? O
but ? ? O
it ? ? O
produced ? ? O
a ? ? O
long ? ? I-disease
lasting ? ? I-disease
rise ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure ? ? I-disease
. ? ? O

Ethyl 5068007 ? I-treatment
alcohol ? ? I-treatment
( ? ? O
0.1 ? ? O
ml ? ? O
/ ? ? O
ml ? ? O
) ? ? O
elicited ? ? O
brisk ? ? I-disease
though ? ? I-disease
brief ? ? I-disease
respiratory ? ? I-disease
stimulation ? ? I-disease
and ? ? O
a ? ? O
short ? ? I-disease
lasting ? ? I-disease
fall ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure.4 ? ? I-disease
. ? ? O

It 5068007 ? O
was ? ? O
shown ? ? O
that ? ? O
the ? ? O
effects ? ? O
of ? ? O
procaine ? ? I-treatment
and ? ? O
nicotine ? ? I-treatment
were ? ? O
not ? ? O
qualitatively ? ? O
altered ? ? O
when ? ? O
the ? ? O
perfusion ? ? O
effluent ? ? O
was ? ? O
collected ? ? O
through ? ? O
a ? ? O
ventral ? ? O
craniotomy ? ? O
instead ? ? O
of ? ? O
the ? ? O
cisterna ? ? O
magna ? ? O
. ? ? O

Epithelial 7499407 ? I-gene
membrane ? ? I-gene
protein-1 ? ? I-gene
, ? ? O
peripheral ? ? I-gene
myelin ? ? I-gene
protein ? ? I-gene
22 ? ? I-gene
, ? ? O
and ? ? O
lens ? ? I-gene
membrane ? ? I-gene
protein ? ? I-gene
20 ? ? I-gene
define ? ? O
a ? ? O
novel ? ? O
gene ? ? O
family ? ? O
. ? ? O

Peripheral 7499407 ? I-gene
myelin ? ? I-gene
protein ? ? I-gene
22 ? ? I-gene
( ? ? O
PMP22 ? ? I-gene
) ? ? O
is ? ? O
expressed ? ? O
in ? ? O
many ? ? O
tissues ? ? O
but ? ? O
mainly ? ? O
by ? ? O
Schwann ? ? O
cells ? ? O
as ? ? O
a ? ? O
component ? ? O
of ? ? O
compact ? ? O
myelin ? ? I-gene
of ? ? O
the ? ? O
peripheral ? ? O
nervous ? ? O
system ? ? O
( ? ? O
PNS ? ? O
) ? ? O
. ? ? O

Mutations 7499407 ? O
affecting ? ? O
PMP22 ? ? I-gene
are ? ? O
associated ? ? O
with ? ? O
hereditary ? ? I-disease
motor ? ? I-disease
and ? ? I-disease
sensory ? ? I-disease
neuropathies ? ? I-disease
. ? ? O

Although 7499407 ? O
these ? ? O
phenotypes ? ? O
are ? ? O
restricted ? ? O
to ? ? O
the ? ? O
PNS ? ? O
, ? ? O
PMP22 ? ? I-gene
is ? ? O
thought ? ? O
to ? ? O
play ? ? O
a ? ? O
dual ? ? O
role ? ? O
in ? ? O
myelin ? ? I-gene
formation ? ? O
and ? ? O
in ? ? O
cell ? ? O
proliferation ? ? O
. ? ? O

We 7499407 ? O
describe ? ? O
the ? ? O
cloning ? ? O
and ? ? O
characterization ? ? O
of ? ? O
epithelial ? ? I-gene
membrane ? ? I-gene
protein-1 ? ? I-gene
( ? ? O
EMP-1 ? ? I-gene
) ? ? O
, ? ? O
a ? ? O
putative ? ? O
four-transmembrane ? ? O
protein ? ? O
of ? ? O
160 ? ? O
amino ? ? O
acids ? ? O
with ? ? O
40 ? ? O
% ? ? O
amino ? ? O
acid ? ? O
identity ? ? O
to ? ? O
PMP22 ? ? I-gene
. ? ? O

EMP-1 7499407 ? I-gene
and ? ? O
PMP22 ? ? I-gene
are ? ? O
co-expressed ? ? O
in ? ? O
most ? ? O
tissues ? ? O
but ? ? O
with ? ? O
differences ? ? O
in ? ? O
relative ? ? O
expression ? ? O
levels ? ? O
. ? ? O

EMP-1 7499407 ? I-gene
is ? ? O
most ? ? O
prominently ? ? O
found ? ? O
in ? ? O
the ? ? O
gastrointestinal ? ? O
tract ? ? O
, ? ? O
skin ? ? O
, ? ? O
lung ? ? O
, ? ? O
and ? ? O
brain ? ? O
but ? ? O
not ? ? O
in ? ? O
liver ? ? O
. ? ? O

In 7499407 ? O
the ? ? O
corpus ? ? O
gastricum ? ? O
, ? ? O
EMP-1 ? ? I-gene
protein ? ? O
can ? ? O
be ? ? O
detected ? ? O
in ? ? O
epithelial ? ? O
cells ? ? O
of ? ? O
the ? ? O
gastric ? ? O
pit ? ? O
and ? ? O
isthmus ? ? O
of ? ? O
the ? ? O
gastric ? ? O
gland ? ? O
in ? ? O
a ? ? O
pattern ? ? O
consistent ? ? O
with ? ? O
plasma ? ? O
membrane ? ? O
association ? ? O
. ? ? O

EMP-1 7499407 ? I-gene
and ? ? O
PMP22 ? ? I-gene
mRNA ? ? O
levels ? ? O
are ? ? O
inversely ? ? O
regulated ? ? O
in ? ? O
the ? ? O
degenerating ? ? O
rat ? ? O
sciatic ? ? O
nerve ? ? O
after ? ? O
injury ? ? O
and ? ? O
by ? ? O
growth ? ? O
arrest ? ? O
in ? ? O
NIH ? ? O
3T3 ? ? O
fibroblasts ? ? O
. ? ? O

The 7499407 ? O
discovery ? ? O
of ? ? O
EMP-1 ? ? I-gene
as ? ? O
the ? ? O
second ? ? O
member ? ? O
of ? ? O
a ? ? O
novel ? ? O
gene ? ? O
family ? ? O
led ? ? O
to ? ? O
the ? ? O
identification ? ? O
of ? ? O
the ? ? O
lens-specific ? ? I-gene
membrane ? ? I-gene
protein ? ? I-gene
20 ? ? I-gene
( ? ? O
MP20 ? ? I-gene
) ? ? O
as ? ? O
a ? ? O
third ? ? O
but ? ? O
distant ? ? O
relative ? ? O
. ? ? O

The 7499407 ? O
proteins ? ? O
of ? ? O
this ? ? O
family ? ? O
are ? ? O
likely ? ? O
to ? ? O
serve ? ? O
similar ? ? O
functions ? ? O
possibly ? ? O
related ? ? O
to ? ? O
cell ? ? O
proliferation ? ? O
and ? ? O
differentiation ? ? O
in ? ? O
a ? ? O
variety ? ? O
of ? ? O
cell ? ? O
types ? ? O
. ? ? O

Neurons 9315897 ? O
promote ? ? O
the ? ? O
translocation ? ? O
of ? ? O
peripheral ? ? I-gene
myelin ? ? I-gene
protein ? ? I-gene
22 ? ? I-gene
into ? ? O
myelin ? ? I-gene
. ? ? O

Schwann 9315897 ? O
cells ? ? O
express ? ? O
low ? ? O
levels ? ? O
of ? ? O
myelin ? ? I-gene
proteins ? ? O
in ? ? O
the ? ? O
absence ? ? O
of ? ? O
neurons ? ? O
. ? ? O

When 9315897 ? O
Schwann ? ? O
cells ? ? O
and ? ? O
neurons ? ? O
are ? ? O
cultured ? ? O
together ? ? O
the ? ? O
production ? ? O
of ? ? O
myelin ? ? I-gene
proteins ? ? O
is ? ? O
elevated ? ? O
, ? ? O
and ? ? O
myelin ? ? I-gene
is ? ? O
formed ? ? O
. ? ? O

For 9315897 ? O
peripheral ? ? I-gene
myelin ? ? I-gene
protein ? ? I-gene
22 ? ? I-gene
( ? ? O
PMP22 ? ? I-gene
) ? ? O
, ? ? O
the ? ? O
exact ? ? O
amount ? ? O
of ? ? O
protein ? ? O
produced ? ? O
is ? ? O
critical ? ? O
, ? ? O
because ? ? O
peripheral ? ? I-disease
neuropathies ? ? I-disease
result ? ? O
from ? ? O
its ? ? O
underexpression ? ? O
or ? ? O
overexpression ? ? O
. ? ? O

In 9315897 ? O
this ? ? O
study ? ? O
we ? ? O
examined ? ? O
the ? ? O
effect ? ? O
of ? ? O
neurons ? ? O
on ? ? O
Schwann ? ? O
cell ? ? O
PMP22 ? ? I-gene
production ? ? O
in ? ? O
culture ? ? O
and ? ? O
in ? ? O
peripheral ? ? O
nerve ? ? O
using ? ? O
metabolic ? ? O
labeling ? ? O
and ? ? O
pulse-chase ? ? O
studies ? ? O
as ? ? O
well ? ? O
as ? ? O
immunocytochemistry ? ? O
. ? ? O

Most 9315897 ? O
of ? ? O
the ? ? O
newly ? ? O
synthesized ? ? O
PMP22 ? ? I-gene
in ? ? O
Schwann ? ? O
cells ? ? O
is ? ? O
rapidly ? ? O
degraded ? ? O
in ? ? O
the ? ? O
endoplasmic ? ? O
reticulum ? ? O
. ? ? O

Only 9315897 ? O
a ? ? O
small ? ? O
proportion ? ? O
of ? ? O
the ? ? O
total ? ? O
PMP22 ? ? I-gene
acquires ? ? O
complex ? ? O
glycosylation ? ? O
and ? ? O
accumulates ? ? O
in ? ? O
the ? ? O
Golgi ? ? O
compartment ? ? O
. ? ? O

This 9315897 ? O
material ? ? O
is ? ? O
translocated ? ? O
to ? ? O
the ? ? O
Schwann ? ? O
cell ? ? O
membrane ? ? O
in ? ? O
detectable ? ? O
amounts ? ? O
only ? ? O
when ? ? O
axonal ? ? O
contact ? ? O
and ? ? O
myelination ? ? O
occur ? ? O
. ? ? O

Myelination 9315897 ? O
does ? ? O
not ? ? O
, ? ? O
however ? ? O
, ? ? O
alter ? ? O
the ? ? O
rapid ? ? O
turnover ? ? O
of ? ? O
PMP22 ? ? I-gene
in ? ? O
Schwann ? ? O
cells ? ? O
. ? ? O

PMP22 9315897 ? I-gene
may ? ? O
therefore ? ? O
be ? ? O
a ? ? O
unique ? ? O
myelin ? ? I-gene
protein ? ? O
in ? ? O
that ? ? O
axonal ? ? O
contact ? ? O
promotes ? ? O
its ? ? O
insertion ? ? O
into ? ? O
the ? ? O
Schwann ? ? O
cell ? ? O
membrane ? ? O
and ? ? O
myelin ? ? I-gene
without ? ? O
altering ? ? O
its ? ? O
rapid ? ? O
turnover ? ? O
rate ? ? O
within ? ? O
the ? ? O
cell ? ? O
. ? ? O

Role 10987826 ? O
of ? ? O
the ? ? O
peripheral ? ? I-gene
myelin ? ? I-gene
protein ? ? I-gene
22 ? ? I-gene
N-linked ? ? O
glycan ? ? O
in ? ? O
oligomer ? ? O
stability ? ? O
. ? ? O

Peripheral 10987826 ? I-gene
myelin ? ? I-gene
protein ? ? I-gene
22 ? ? I-gene
( ? ? O
PMP22 ? ? I-gene
) ? ? O
is ? ? O
a ? ? O
22-kDa ? ? O
glycoprotein ? ? O
containing ? ? O
a ? ? O
single ? ? O
N-linked ? ? O
carbohydrate ? ? O
moiety ? ? O
. ? ? O

This 10987826 ? O
posttranslational ? ? O
modification ? ? O
is ? ? O
conserved ? ? O
in ? ? O
PMP22 ? ? I-gene
across ? ? O
species ? ? O
and ? ? O
within ? ? O
members ? ? O
of ? ? O
the ? ? O
PMP22 ? ? I-gene
gene ? ? O
family ? ? O
; ? ? O
however ? ? O
, ? ? O
the ? ? O
function ? ? O
of ? ? O
the ? ? O
oligosaccharide ? ? O
is ? ? O
not ? ? O
known ? ? O
. ? ? O

To 10987826 ? O
study ? ? O
the ? ? O
role ? ? O
of ? ? O
the ? ? O
PMP22 ? ? I-gene
carbohydrate ? ? O
, ? ? O
site-directed ? ? O
mutagenesis ? ? O
was ? ? O
used ? ? O
to ? ? O
alter ? ? O
the ? ? O
glycosylation ? ? O
consensus ? ? O
sequence ? ? O
and ? ? O
produce ? ? O
a ? ? O
glycosylation-deficient ? ? O
mutant ? ? O
protein ? ? O
. ? ? O

This 10987826 ? O
modified ? ? O
PMP22 ? ? I-gene
was ? ? O
expressed ? ? O
in ? ? O
primary ? ? O
Schwann ? ? O
cells ? ? O
( ? ? O
SCs ? ? O
) ? ? O
, ? ? O
and ? ? O
the ? ? O
effect ? ? O
of ? ? O
the ? ? O
N-glycan ? ? O
on ? ? O
the ? ? O
turnover ? ? O
rate ? ? O
, ? ? O
oligomerization ? ? O
, ? ? O
and ? ? O
intracellular ? ? O
trafficking ? ? O
of ? ? O
PMP22 ? ? I-gene
was ? ? O
determined ? ? O
. ? ? O

Our 10987826 ? O
data ? ? O
show ? ? O
a ? ? O
slight ? ? O
decrease ? ? O
in ? ? O
turnover ? ? O
rate ? ? O
from ? ? O
a ? ? O
half-life ? ? O
of ? ? O
approximately ? ? O
70 ? ? O
min ? ? O
for ? ? O
the ? ? O
wild-type ? ? O
( ? ? O
wt ? ? O
) ? ? O
protein ? ? O
to ? ? O
100 ? ? O
min ? ? O
for ? ? O
the ? ? O
glycosylation ? ? O
mutant ? ? O
. ? ? O

Although 10987826 ? O
the ? ? O
presence ? ? O
of ? ? O
glycosylation-deficient ? ? O
PMP22 ? ? I-gene
oligomers ? ? O
could ? ? O
be ? ? O
detected ? ? O
in ? ? O
SCs ? ? O
, ? ? O
we ? ? O
observed ? ? O
a ? ? O
decrease ? ? O
in ? ? O
oligomer ? ? O
stability ? ? O
compared ? ? O
with ? ? O
the ? ? O
wt ? ? O
oligomers ? ? O
. ? ? O

Both 10987826 ? O
wt ? ? O
and ? ? O
mutant ? ? O
proteins ? ? O
showed ? ? O
similar ? ? O
localization ? ? O
in ? ? O
the ? ? O
endoplasmic ? ? O
reticulum ? ? O
and ? ? O
Golgi ? ? O
compartments ? ? O
and ? ? O
were ? ? O
transported ? ? O
to ? ? O
the ? ? O
SC ? ? O
surface ? ? O
. ? ? O

These 10987826 ? O
results ? ? O
suggest ? ? O
that ? ? O
the ? ? O
N-glycan ? ? O
of ? ? O
PMP22 ? ? I-gene
facilitates ? ? O
, ? ? O
in ? ? O
part ? ? O
, ? ? O
the ? ? O
stability ? ? O
of ? ? O
the ? ? O
PMP22 ? ? I-gene
oligomer ? ? O
; ? ? O
however ? ? O
, ? ? O
the ? ? O
implications ? ? O
of ? ? O
PMP22 ? ? I-gene
oligomerization ? ? O
remain ? ? O
unknown ? ? O
. ? ? O

Trisomy 11903333 ? I-disease
17p10-p12 ? ? I-disease
resulting ? ? O
from ? ? O
a ? ? O
supernumerary ? ? O
marker ? ? O
chromosome ? ? O
derived ? ? O
from ? ? O
chromosome ? ? O
17 ? ? O
: ? ? O
molecular ? ? O
analysis ? ? O
and ? ? O
delineation ? ? O
of ? ? O
the ? ? O
phenotype ? ? O
. ? ? O

We 11903333 ? O
report ? ? O
a ? ? O
5-year-old ? ? O
boy ? ? O
with ? ? O
a ? ? O
small ? ? O
de ? ? O
novo ? ? O
marker ? ? O
chromosome ? ? O
derived ? ? O
from ? ? O
the ? ? O
proximal ? ? O
short ? ? O
arm ? ? O
of ? ? O
chromosome ? ? O
17 ? ? O
. ? ? O

His 11903333 ? O
clinical ? ? O
features ? ? O
include ? ? O
hypotonia ? ? I-disease
, ? ? O
global ? ? I-disease
developmental ? ? I-disease
delay ? ? I-disease
, ? ? O
oval ? ? I-disease
face ? ? I-disease
with ? ? I-disease
large ? ? I-disease
nose ? ? I-disease
and ? ? I-disease
prominent ? ? I-disease
ears ? ? I-disease
, ? ? O
and ? ? O
ligamentous ? ? I-disease
laxity ? ? I-disease
of ? ? I-disease
the ? ? I-disease
fingers ? ? I-disease
. ? ? O

Magnetic 11903333 ? O
resonance ? ? O
imaging ? ? O
of ? ? O
the ? ? O
brain ? ? O
demonstrated ? ? O
mildly ? ? I-disease
delayed ? ? I-disease
myelination ? ? I-disease
. ? ? O

G-band 11903333 ? O
chromosome ? ? O
analysis ? ? O
revealed ? ? O
mosaicism ? ? O
for ? ? O
a ? ? O
small ? ? O
marker ? ? O
chromosome ? ? O
in ? ? O
85 ? ? O
% ? ? O
of ? ? O
the ? ? O
peripheral ? ? O
blood ? ? O
cells ? ? O
analyzed ? ? O
. ? ? O

Fluorescence 11903333 ? O
in ? ? O
situ ? ? O
hybridization ? ? O
and ? ? O
microsatellite ? ? O
polymorphism ? ? O
studies ? ? O
showed ? ? O
that ? ? O
the ? ? O
der ? ? I-gene
( ? ? I-gene
17 ? ? I-gene
) ? ? O
was ? ? O
of ? ? O
maternal ? ? O
origin ? ? O
and ? ? O
included ? ? O
genetic ? ? O
material ? ? O
from ? ? O
the ? ? O
17p10-p12 ? ? O
region ? ? O
, ? ? O
but ? ? O
did ? ? O
not ? ? O
contain ? ? O
the ? ? O
PMP22 ? ? I-gene
gene ? ? O
. ? ? O

One 11903333 ? O
breakpoint ? ? O
mapped ? ? O
within ? ? O
the ? ? O
centromere ? ? O
and ? ? O
the ? ? O
second ? ? O
breakpoint ? ? O
mapped ? ? O
adjacent ? ? O
to ? ? O
the ? ? O
Charcot-Marie-Tooth ? ? I-gene
disease ? ? I-gene
type ? ? I-gene
1A ? ? I-gene
proximal ? ? I-gene
low-copy ? ? I-gene
repeat ? ? I-gene
( ? ? O
CMT1A-REP ? ? I-gene
) ? ? O
. ? ? O

We 11903333 ? O
compare ? ? O
the ? ? O
clinical ? ? O
characteristics ? ? O
of ? ? O
our ? ? O
patient ? ? O
with ? ? O
those ? ? O
previously ? ? O
reported ? ? O
to ? ? O
have ? ? O
a ? ? O
duplication ? ? O
involving ? ? O
the ? ? O
proximal ? ? O
short ? ? O
arm ? ? O
region ? ? O
of ? ? O
chromosome ? ? O
17 ? ? O
to ? ? O
further ? ? O
delineate ? ? O
the ? ? O
phenotype ? ? O
of ? ? O
trisomy ? ? I-disease
17pl0-p12 ? ? I-disease
. ? ? O

Influence 12648019 ? O
of ? ? O
hydroxypropyl ? ? I-treatment
beta-cyclodextrin ? ? I-treatment
on ? ? O
the ? ? O
corneal ? ? O
permeation ? ? O
of ? ? O
pilocarpine ? ? I-treatment
. ? ? O

The 12648019 ? O
influence ? ? O
of ? ? O
hydroxypropyl ? ? I-treatment
beta-cyclodextrin ? ? I-treatment
( ? ? O
HPbetaCD ? ? I-treatment
) ? ? O
on ? ? O
the ? ? O
corneal ? ? O
permeation ? ? O
of ? ? O
pilocarpine ? ? I-treatment
nitrate ? ? I-treatment
was ? ? O
investigated ? ? O
by ? ? O
an ? ? O
in ? ? O
vitro ? ? O
permeability ? ? O
study ? ? O
using ? ? O
isolated ? ? O
rabbit ? ? O
cornea ? ? O
. ? ? O

Pupillary-response 12648019 ? O
pattern ? ? O
to ? ? O
pilocarpine ? ? I-treatment
nitrate ? ? I-treatment
with ? ? O
and ? ? O
without ? ? O
HPbetaCD ? ? I-treatment
was ? ? O
examined ? ? O
in ? ? O
rabbit ? ? O
eye ? ? O
. ? ? O

Corneal 12648019 ? O
permeation ? ? O
of ? ? O
pilocarpine ? ? I-treatment
nitrate ? ? I-treatment
was ? ? O
found ? ? O
to ? ? O
be ? ? O
four ? ? O
times ? ? O
higher ? ? O
after ? ? O
adding ? ? O
HPbetaCD ? ? I-treatment
into ? ? O
the ? ? O
formulation ? ? O
. ? ? O

The 12648019 ? O
reduction ? ? I-disease
of ? ? I-disease
pupil ? ? I-disease
diameter ? ? I-disease
( ? ? O
miosis ? ? I-disease
) ? ? O
by ? ? O
pilocarpine ? ? I-treatment
nitrate ? ? I-treatment
was ? ? O
significantly ? ? O
increased ? ? O
as ? ? O
a ? ? O
result ? ? O
of ? ? O
HPbetaCD ? ? I-treatment
addition ? ? O
into ? ? O
the ? ? O
simple ? ? O
aqueous ? ? O
solution ? ? O
of ? ? O
the ? ? O
active ? ? O
substance ? ? O
. ? ? O

The 12648019 ? O
highest ? ? O
miotic ? ? I-disease
response ? ? I-disease
was ? ? O
obtained ? ? O
with ? ? O
the ? ? O
formulation ? ? O
prepared ? ? O
in ? ? O
a ? ? O
vehicle ? ? O
of ? ? O
Carbopol ? ? I-treatment
940 ? ? I-treatment
. ? ? O

It 12648019 ? O
is ? ? O
suggested ? ? O
that ? ? O
ocular ? ? O
bioavailability ? ? O
of ? ? O
pilocarpine ? ? I-treatment
nitrate ? ? I-treatment
could ? ? O
be ? ? O
improved ? ? O
by ? ? O
the ? ? O
addition ? ? O
of ? ? O
HPbetaCD ? ? I-treatment
. ? ? O

Plasminogen 14609555 ? I-gene
activator ? ? I-gene
activity ? ? I-gene
and ? ? O
inhibition ? ? O
in ? ? O
rabbit ? ? O
tears ? ? O
after ? ? O
photorefractive ? ? I-treatment
keratectomy ? ? I-treatment
. ? ? O

Plasminogen 14609555 ? I-treatment
activator ? ? I-treatment
is ? ? O
a ? ? O
normal ? ? O
component ? ? O
of ? ? O
tear ? ? O
fluid ? ? O
that ? ? O
plays ? ? O
a ? ? O
role ? ? O
in ? ? O
corneal ? ? I-disease
wound ? ? I-disease
healing ? ? O
processes ? ? O
. ? ? O

This 14609555 ? O
work ? ? O
examines ? ? O
whether ? ? O
inhibitor-induced ? ? O
low ? ? O
levels ? ? O
of ? ? O
plasminogen ? ? I-gene
activator ? ? I-gene
activity ? ? I-gene
( ? ? O
PAA ? ? I-gene
) ? ? O
during ? ? O
corneal ? ? O
re-epithelialization ? ? O
after ? ? O
excimer ? ? I-treatment
laser ? ? I-treatment
photorefractive ? ? I-treatment
keratectomy ? ? I-treatment
( ? ? O
PRK ? ? I-treatment
) ? ? O
correlates ? ? O
with ? ? O
the ? ? O
eventual ? ? O
occurrence ? ? O
of ? ? O
haze ? ? I-disease
in ? ? O
rabbit ? ? O
eyes ? ? O
. ? ? O

Tear 14609555 ? O
samples ? ? O
were ? ? O
collected ? ? O
with ? ? O
glass ? ? O
capillaries ? ? O
from ? ? O
16 ? ? O
eyes ? ? O
of ? ? O
eight ? ? O
New ? ? O
Zealand ? ? O
rabbits ? ? O
, ? ? O
using ? ? O
i.m ? ? O
. ? ? O

injection 14609555 ? O
of ? ? O
pilocarpine ? ? I-treatment
hydrochloride ? ? I-treatment
for ? ? O
stimulation ? ? O
. ? ? O

Tears 14609555 ? O
were ? ? O
collected ? ? O
before ? ? O
and ? ? O
after ? ? O
PRK ? ? I-treatment
surgery ? ? O
, ? ? O
and ? ? O
then ? ? O
daily ? ? O
for ? ? O
5 ? ? O
days ? ? O
, ? ? O
and ? ? O
every ? ? O
fourth ? ? O
day ? ? O
thereafter ? ? O
for ? ? O
3 ? ? O
months ? ? O
. ? ? O

Both 14609555 ? O
eyes ? ? O
underwent ? ? O
PRK ? ? I-treatment
treatment ? ? O
. ? ? O

One 14609555 ? O
eye ? ? O
of ? ? O
each ? ? O
rabbit ? ? O
was ? ? O
treated ? ? O
as ? ? O
a ? ? O
control ? ? O
while ? ? O
the ? ? O
contralateral ? ? O
eye ? ? O
was ? ? O
treated ? ? O
with ? ? O
aprotinin ? ? I-treatment
, ? ? O
a ? ? O
serine ? ? I-gene
protease ? ? I-gene
inhibitor ? ? O
, ? ? O
over ? ? O
the ? ? O
first ? ? O
7 ? ? O
days ? ? O
. ? ? O

PAA 14609555 ? I-gene
in ? ? O
the ? ? O
tear ? ? O
samples ? ? O
was ? ? O
measured ? ? O
by ? ? O
a ? ? O
spectrophotometric ? ? O
method ? ? O
using ? ? O
human ? ? O
plasminogen ? ? I-gene
and ? ? O
chromogenic ? ? O
peptide ? ? O
substrate ? ? O
S-2251 ? ? I-gene
. ? ? O

For 14609555 ? O
the ? ? O
eight ? ? O
control ? ? O
eyes ? ? O
after ? ? O
PRK ? ? I-treatment
, ? ? O
the ? ? O
PAA ? ? I-gene
values ? ? O
were ? ? O
significantly ? ? O
lower ? ? O
( ? ? O
day ? ? O
1 ? ? O
) ? ? O
and ? ? O
higher ? ? O
( ? ? O
days ? ? O
2 ? ? O
and ? ? O
3 ? ? O
) ? ? O
than ? ? O
the ? ? O
equilibrium ? ? O
PAA ? ? I-gene
( ? ? O
p ? ? O
< ? ? O
0.001 ? ? O
) ? ? O
. ? ? O

The 14609555 ? O
corneas ? ? O
remained ? ? O
clear ? ? O
in ? ? O
each ? ? O
of ? ? O
these ? ? O
control ? ? O
eyes ? ? O
. ? ? O

For 14609555 ? O
the ? ? O
eight ? ? O
contralateral ? ? O
aprotinin-treated ? ? I-treatment
eyes ? ? O
after ? ? O
PRK ? ? I-treatment
, ? ? O
the ? ? O
PAA ? ? I-gene
values ? ? O
on ? ? O
days ? ? O
1-7 ? ? O
were ? ? O
significantly ? ? O
lower ? ? O
than ? ? O
the ? ? O
equilibrium ? ? O
PAA ? ? I-gene
( ? ? O
p ? ? O
< ? ? O
0.001 ? ? O
) ? ? O
. ? ? O

All 14609555 ? O
eight ? ? O
of ? ? O
these ? ? O
aprotinin-treated ? ? I-treatment
eyes ? ? O
developed ? ? O
corneal ? ? I-disease
haze ? ? I-disease
after ? ? O
2 ? ? O
months ? ? O
. ? ? O

There 14609555 ? O
was ? ? O
no ? ? O
significant ? ? O
difference ? ? O
( ? ? O
p=0.06 ? ? O
) ? ? O
between ? ? O
control ? ? O
and ? ? O
aprotinin-treated ? ? I-treatment
eyes ? ? O
for ? ? O
the ? ? O
equilibrium ? ? O
PAA ? ? I-gene
after ? ? O
19 ? ? O
days ? ? O
. ? ? O

We 14609555 ? O
conclude ? ? O
that ? ? O
a ? ? O
corneal ? ? I-disease
wound ? ? I-disease
healing ? ? I-disease
abnormality ? ? I-disease
( ? ? O
haze ? ? I-disease
) ? ? O
develops ? ? O
in ? ? O
rabbit ? ? O
eyes ? ? O
after ? ? O
PRK ? ? I-treatment
when ? ? O
PAA ? ? I-gene
levels ? ? O
are ? ? O
reduced ? ? O
using ? ? O
aprotinin ? ? I-treatment
for ? ? O
a ? ? O
week ? ? O
following ? ? O
PRK ? ? I-treatment
. ? ? O

Oral 14644860 ? I-treatment
pilocarpine ? ? I-treatment
for ? ? O
the ? ? O
treatment ? ? O
of ? ? O
ocular ? ? I-disease
symptoms ? ? I-disease
in ? ? O
patients ? ? O
with ? ? O
Sjogren ? ? I-disease
's ? ? I-disease
syndrome ? ? I-disease
: ? ? O
a ? ? O
randomised ? ? O
12 ? ? O
week ? ? O
controlled ? ? O
study ? ? O
. ? ? O

OBJECTIVE 14644860 ? O
: ? ? O
To ? ? O
evaluate ? ? O
the ? ? O
efficacy ? ? O
and ? ? O
side ? ? O
effects ? ? O
of ? ? O
oral ? ? I-treatment
pilocarpine ? ? I-treatment
for ? ? O
the ? ? O
treatment ? ? O
of ? ? O
ocular ? ? I-disease
symptoms ? ? I-disease
in ? ? O
patients ? ? O
with ? ? O
primary ? ? I-disease
Sjogren ? ? I-disease
's ? ? I-disease
syndrome ? ? I-disease
( ? ? O
SS ? ? I-disease
) ? ? O
. ? ? O

METHODS 14644860 ? O
: ? ? O
A ? ? O
12 ? ? O
week ? ? O
, ? ? O
single ? ? O
centre ? ? O
, ? ? O
randomised ? ? O
controlled ? ? O
study ? ? O
was ? ? O
performed ? ? O
. ? ? O

Twenty 14644860 ? O
nine ? ? O
patients ? ? O
were ? ? O
randomly ? ? O
assigned ? ? O
to ? ? O
receive ? ? O
oral ? ? I-treatment
pilocarpine ? ? I-treatment
( ? ? O
5 ? ? O
mg ? ? O
twice ? ? O
a ? ? O
day ? ? O
) ? ? O
, ? ? O
28 ? ? O
only ? ? O
artificial ? ? I-treatment
tears ? ? I-treatment
, ? ? O
and ? ? O
28 ? ? O
inferior ? ? I-treatment
puncta ? ? I-treatment
occlusion ? ? I-treatment
. ? ? O

Patients 14644860 ? O
receiving ? ? O
oral ? ? I-treatment
pilocarpine ? ? I-treatment
and ? ? O
those ? ? O
with ? ? O
inferior ? ? I-treatment
puncta ? ? I-treatment
occlusion ? ? I-treatment
also ? ? O
received ? ? O
artificial ? ? I-treatment
tears ? ? I-treatment
. ? ? O

Patients 14644860 ? O
were ? ? O
evaluated ? ? O
at ? ? O
baseline ? ? O
and ? ? O
throughout ? ? O
the ? ? O
study ? ? O
for ? ? O
their ? ? O
subjective ? ? O
global ? ? O
assessment ? ? O
of ? ? O
dry ? ? I-disease
eyes ? ? I-disease
and ? ? O
for ? ? O
their ? ? O
objective ? ? O
assessment ? ? O
of ? ? O
dry ? ? I-disease
eyes ? ? I-disease
( ? ? O
Schirmer's-I ? ? O
test ? ? O
, ? ? O
rose ? ? O
bengal ? ? O
test ? ? O
, ? ? O
and ? ? O
imprint ? ? O
test ? ? O
) ? ? O
. ? ? O

RESULTS 14644860 ? O
: ? ? O
Patients ? ? O
taking ? ? O
oral ? ? I-treatment
pilocarpine ? ? I-treatment
had ? ? O
significant ? ? O
improvement ? ? O
in ? ? O
subjective ? ? O
global ? ? O
assessment ? ? O
of ? ? O
dry ? ? I-disease
eyes ? ? I-disease
, ? ? O
as ? ? O
was ? ? O
evaluated ? ? O
by ? ? O
improvement ? ? O
of ? ? O
> ? ? O
55 ? ? O
mm ? ? O
on ? ? O
a ? ? O
visual ? ? O
analogue ? ? O
scale ? ? O
( ? ? O
VAS ? ? O
) ? ? O
for ? ? O
responses ? ? O
to ? ? O
the ? ? O
eye ? ? O
questionnaire ? ? O
, ? ? O
compared ? ? O
with ? ? O
patients ? ? O
treated ? ? O
with ? ? O
artificial ? ? I-treatment
tears ? ? I-treatment
( ? ? O
p ? ? O
< ? ? O
0.001 ? ? O
) ? ? O
and ? ? O
those ? ? O
with ? ? O
inferior ? ? I-treatment
puncta ? ? I-treatment
occlusion ? ? I-treatment
( ? ? O
p ? ? O
< ? ? O
0.05 ? ? O
) ? ? O
. ? ? O

Furthermore 14644860 ? O
, ? ? O
patients ? ? O
receiving ? ? O
oral ? ? I-treatment
pilocarpine ? ? I-treatment
also ? ? O
showed ? ? O
greater ? ? O
objective ? ? O
improvement ? ? O
, ? ? O
as ? ? O
measured ? ? O
by ? ? O
the ? ? O
rose ? ? O
bengal ? ? O
test ? ? O
( ? ? O
p ? ? O
< ? ? O
0.05 ? ? O
) ? ? O
, ? ? O
while ? ? O
Schirmer's-I ? ? O
test ? ? O
showed ? ? O
no ? ? O
differences ? ? O
between ? ? O
the ? ? O
treated ? ? O
groups ? ? O
. ? ? O

Commonly 14644860 ? O
reported ? ? O
adverse ? ? O
events ? ? O
were ? ? O
headache ? ? I-disease
, ? ? O
increased ? ? I-disease
sweating ? ? I-disease
, ? ? O
nausea ? ? I-disease
, ? ? O
and ? ? O
vomiting ? ? I-disease
in ? ? O
the ? ? O
pilocarpine ? ? I-treatment
group ? ? O
, ? ? O
while ? ? O
one ? ? O
patient ? ? O
in ? ? O
the ? ? O
inferior ? ? I-treatment
puncta ? ? I-treatment
occlusion ? ? I-treatment
group ? ? O
had ? ? O
blepharitis ? ? I-disease
and ? ? O
was ? ? O
withdrawn ? ? O
from ? ? O
the ? ? O
study ? ? O
. ? ? O

CONCLUSION 14644860 ? O
: ? ? O
10 ? ? O
mg ? ? O
of ? ? O
pilocarpine ? ? I-treatment
daily ? ? O
given ? ? O
to ? ? O
patients ? ? O
with ? ? O
SS ? ? I-disease
for ? ? O
12 ? ? O
weeks ? ? O
had ? ? O
a ? ? O
beneficial ? ? O
effect ? ? O
on ? ? O
subjective ? ? O
eye ? ? O
symptoms ? ? O
, ? ? O
as ? ? O
evaluated ? ? O
by ? ? O
improvement ? ? O
> ? ? O
55 ? ? O
mm ? ? O
on ? ? O
a ? ? O
VAS ? ? O
. ? ? O

Additionally 14644860 ? O
, ? ? O
an ? ? O
improvement ? ? O
of ? ? O
rose ? ? O
bengal ? ? O
staining ? ? O
was ? ? O
noted ? ? O
, ? ? O
but ? ? O
an ? ? O
increase ? ? I-disease
in ? ? I-disease
tear ? ? I-disease
production ? ? I-disease
, ? ? O
as ? ? O
measured ? ? O
by ? ? O
the ? ? O
Schirmer-I ? ? O
test ? ? O
, ? ? O
was ? ? O
not ? ? O
substantiated ? ? O
. ? ? O

Dual-stimuli-responsive 14698590 ? O
hydrogels ? ? I-treatment
based ? ? O
on ? ? O
poly ? ? I-treatment
( ? ? I-treatment
N-isopropylacrylamide ? ? I-treatment
) ? ? O
/ ? ? O
chitosan ? ? I-treatment
semi-interpenetrating ? ? O
networks ? ? O
. ? ? O

The 14698590 ? O
synthesis ? ? O
and ? ? O
characterisation ? ? O
of ? ? O
semi-interpenetrating ? ? O
polymeric ? ? O
networks ? ? O
obtained ? ? O
by ? ? O
the ? ? O
radical-induced ? ? O
polymerisation ? ? O
of ? ? O
N-isopropylacrylamide ? ? I-treatment
in ? ? O
the ? ? O
presence ? ? O
of ? ? O
chitosan ? ? I-treatment
using ? ? O
tetraethyleneglycoldiacrylate ? ? I-treatment
as ? ? O
the ? ? O
crosslinker ? ? O
is ? ? O
described ? ? O
. ? ? O

The 14698590 ? O
influence ? ? O
of ? ? O
the ? ? O
degree ? ? O
of ? ? O
crosslinking ? ? O
and ? ? O
that ? ? O
of ? ? O
the ? ? O
ratio ? ? O
of ? ? O
chitosan ? ? I-treatment
to ? ? O
poly ? ? I-treatment
( ? ? I-treatment
N-isopropylacrylamide ? ? I-treatment
) ? ? O
on ? ? O
the ? ? O
`` ? ? O
pH ? ? O
/ ? ? O
temperature ? ? O
induced ? ? O
'' ? ? O
phase ? ? O
transition ? ? O
behaviour ? ? O
and ? ? O
swelling ? ? O
characteristics ? ? O
of ? ? O
the ? ? O
hydrogel ? ? I-treatment
system ? ? O
are ? ? O
investigated ? ? O
. ? ? O

The 14698590 ? O
ability ? ? O
of ? ? O
the ? ? O
same ? ? O
system ? ? O
to ? ? O
act ? ? O
as ? ? O
a ? ? O
controlled ? ? O
release ? ? O
vehicle ? ? O
for ? ? O
pilocarpine ? ? I-treatment
hydrochloride ? ? I-treatment
is ? ? O
evaluated ? ? O
. ? ? O

[ 15059558 ? O
Ocular ? ? O
pharmacokinetics ? ? O
of ? ? O
0.5 ? ? O
% ? ? O
pilocarpine ? ? I-treatment
with ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
in ? ? O
rabbits ? ? O
] ? ? O
. ? ? O

OBJECTIVE 15059558 ? O
: ? ? O
To ? ? O
compare ? ? O
the ? ? O
pharmacokinetics ? ? O
of ? ? O
0.5 ? ? O
% ? ? O
pilocarpine ? ? I-treatment
containing ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
with ? ? O
1 ? ? O
% ? ? O
generic ? ? O
pilocarpine ? ? I-treatment
solution ? ? O
. ? ? O

METHODS 15059558 ? O
: ? ? O
One ? ? O
hundred ? ? O
albino ? ? I-disease
rabbits ? ? O
were ? ? O
divided ? ? O
into ? ? O
20 ? ? O
groups ? ? O
, ? ? O
each ? ? O
consisting ? ? O
of ? ? O
5 ? ? O
animals ? ? O
. ? ? O

Ten 15059558 ? O
groups ? ? O
received ? ? O
0.5 ? ? O
% ? ? O
pilocarpine ? ? I-treatment
containing ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
and ? ? O
10 ? ? O
groups ? ? O
received ? ? O
1 ? ? O
% ? ? O
generic ? ? O
pilocarpine ? ? I-treatment
solution ? ? O
as ? ? O
control ? ? O
. ? ? O

The 15059558 ? O
aqueous ? ? O
humor ? ? O
was ? ? O
withdrawn ? ? O
at ? ? O
5 ? ? O
, ? ? O
10 ? ? O
, ? ? O
20 ? ? O
, ? ? O
30 ? ? O
, ? ? O
40 ? ? O
, ? ? O
60 ? ? O
, ? ? O
90 ? ? O
, ? ? O
120 ? ? O
, ? ? O
150 ? ? O
, ? ? O
and ? ? O
180 ? ? O
min ? ? O
after ? ? O
instillation ? ? O
. ? ? O

The 15059558 ? O
drug ? ? O
was ? ? O
extracted ? ? O
from ? ? O
aqueous ? ? O
humor ? ? O
with ? ? O
dichloromethane ? ? O
and ? ? O
was ? ? O
detected ? ? O
by ? ? O
reversed ? ? O
phase ? ? O
high ? ? O
performance ? ? O
liquid ? ? O
chromatography ? ? O
( ? ? O
HPLC ? ? O
) ? ? O
. ? ? O

RESULTS 15059558 ? O
: ? ? O
The ? ? O
average ? ? O
recovery ? ? O
rate ? ? O
of ? ? O
pilocarpine ? ? I-treatment
from ? ? O
aqueous ? ? O
humor ? ? O
was ? ? O
98.2 ? ? O
% ? ? O
. ? ? O

The 15059558 ? O
minimum ? ? O
detectable ? ? O
concentration ? ? O
was ? ? O
0.025 ? ? O
micro ? ? O
g ? ? O
/ ? ? O
ml ? ? O
. ? ? O

The 15059558 ? O
peak ? ? O
concentration ? ? O
and ? ? O
half-life ? ? O
of ? ? O
pilocarpine ? ? I-treatment
in ? ? O
aqueous ? ? O
humor ? ? O
were ? ? O
4.46 ? ? O
micro ? ? O
g ? ? O
/ ? ? O
ml ? ? O
at ? ? O
10 ? ? O
min ? ? O
and ? ? O
31.83 ? ? O
min ? ? O
, ? ? O
respectively ? ? O
, ? ? O
in ? ? O
the ? ? O
experimental ? ? O
group ? ? O
. ? ? O

Whereas 15059558 ? O
, ? ? O
the ? ? O
peak ? ? O
concentration ? ? O
and ? ? O
half-life ? ? O
of ? ? O
pilocarpine ? ? I-treatment
in ? ? O
aqueous ? ? O
humor ? ? O
were ? ? O
2.25 ? ? O
micro ? ? O
g ? ? O
/ ? ? O
ml ? ? O
at ? ? O
20 ? ? O
min ? ? O
and ? ? O
22.98 ? ? O
min ? ? O
, ? ? O
respectively ? ? O
, ? ? O
in ? ? O
the ? ? O
control ? ? O
group ? ? O
. ? ? O

The 15059558 ? O
peak ? ? O
concentration ? ? O
of ? ? O
pilocarpine ? ? I-treatment
in ? ? O
aqueous ? ? O
humor ? ? O
in ? ? O
the ? ? O
experimental ? ? O
group ? ? O
was ? ? O
1.98 ? ? O
( ? ? O
P ? ? O
< ? ? O
0.05 ? ? O
) ? ? O
times ? ? O
higher ? ? O
than ? ? O
the ? ? O
control ? ? O
group ? ? O
. ? ? O

The 15059558 ? O
area ? ? O
under ? ? O
curve ? ? O
of ? ? O
the ? ? O
drug ? ? O
concentration-time ? ? O
( ? ? O
AUC ? ? O
( ? ? O
0 ? ? O
- ? ? O
180 ? ? O
) ? ? O
) ? ? O
in ? ? O
the ? ? O
experimental ? ? O
group ? ? O
was ? ? O
1.75 ? ? O
times ? ? O
higher ? ? O
than ? ? O
the ? ? O
control ? ? O
group ? ? O
. ? ? O

CONCLUSION 15059558 ? O
: ? ? O
Pilocarpine ? ? I-treatment
( ? ? O
0.5 ? ? O
% ? ? O
) ? ? O
containing ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
significantly ? ? O
increased ? ? O
the ? ? O
peak ? ? O
concentration ? ? O
of ? ? O
pilocarpine ? ? I-treatment
, ? ? O
shortened ? ? O
the ? ? O
time ? ? O
of ? ? O
reaching ? ? O
peak ? ? O
concentration ? ? O
and ? ? O
prolonged ? ? O
the ? ? O
half-life ? ? O
in ? ? O
aqueous ? ? O
humor ? ? O
. ? ? O

These 15059558 ? O
results ? ? O
indicate ? ? O
that ? ? O
0.5 ? ? O
% ? ? O
pilocarpine ? ? I-treatment
with ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
significantly ? ? O
increases ? ? O
ocular ? ? O
bioavailability ? ? O
of ? ? O
pilocarpine ? ? I-treatment
. ? ? O

Lipopolysaccharide-induced 15509232 ? I-disease
febrile ? ? I-disease
convulsions ? ? I-disease
in ? ? O
the ? ? O
rat ? ? O
: ? ? O
short-term ? ? O
sequelae ? ? O
. ? ? O

PURPOSE 15509232 ? O
: ? ? O
Febrile ? ? I-gene
convulsions ? ? I-gene
( ? ? O
FCs ? ? I-gene
) ? ? O
occur ? ? O
in ? ? O
children ? ? O
as ? ? O
a ? ? O
result ? ? O
of ? ? O
fever ? ? I-disease
. ? ? O

The 15509232 ? O
mechanisms ? ? O
involved ? ? O
in ? ? O
the ? ? O
genesis ? ? O
of ? ? O
FCs ? ? I-disease
and ? ? O
their ? ? O
long-term ? ? O
consequences ? ? O
on ? ? O
brain ? ? O
development ? ? O
remain ? ? O
unclear ? ? O
. ? ? O

We 15509232 ? O
have ? ? O
developed ? ? O
a ? ? O
model ? ? O
of ? ? O
FC ? ? I-disease
, ? ? O
by ? ? O
using ? ? O
fever ? ? I-disease
as ? ? O
a ? ? O
parameter ? ? O
, ? ? O
to ? ? O
test ? ? O
the ? ? O
hypothesis ? ? O
that ? ? O
fever ? ? I-disease
can ? ? O
lower ? ? O
seizure ? ? I-disease
threshold ? ? O
and ? ? O
to ? ? O
examine ? ? O
the ? ? O
neurologic ? ? O
sequelae ? ? O
of ? ? O
FCs ? ? I-disease
. ? ? O

METHODS 15509232 ? O
: ? ? O
Fourteen-day-old ? ? O
rat ? ? O
pups ? ? O
equipped ? ? O
with ? ? O
body-temperature ? ? O
telemetry ? ? O
devices ? ? O
exhibited ? ? O
approximately ? ? O
1.5 ? ? O
degrees ? ? O
C ? ? O
fevers ? ? I-disease
after ? ? O
lipopolysaccharide ? ? O
( ? ? O
Escherichia ? ? O
coli ? ? O
, ? ? O
200 ? ? O
microg ? ? O
/ ? ? O
kg ? ? O
) ? ? O
. ? ? O

During 15509232 ? O
such ? ? O
fevers ? ? I-disease
, ? ? O
concurrently ? ? O
administered ? ? O
doses ? ? O
of ? ? O
kainic ? ? O
acid ? ? O
that ? ? O
are ? ? O
normally ? ? O
subconvulsant ? ? O
were ? ? O
used ? ? O
to ? ? O
induce ? ? O
convulsions ? ? I-disease
with ? ? O
fever ? ? O
. ? ? O

Animals 15509232 ? O
were ? ? O
then ? ? O
killed ? ? O
at ? ? O
varying ? ? O
times ? ? O
for ? ? O
pathological ? ? O
and ? ? O
immunohistochemical ? ? O
studies ? ? O
. ? ? O

RESULTS 15509232 ? O
: ? ? O
The ? ? O
pairing ? ? O
of ? ? O
lipopolysaccharide ? ? O
and ? ? O
subconvulsant ? ? O
kainic ? ? O
acid ? ? O
resulted ? ? O
in ? ? O
convulsions ? ? I-disease
in ? ? O
approximately ? ? O
50 ? ? O
% ? ? O
of ? ? O
febrile ? ? I-disease
animals ? ? O
, ? ? O
with ? ? O
very ? ? O
low ? ? O
mortality ? ? O
. ? ? O

To 15509232 ? O
study ? ? O
the ? ? O
neural ? ? O
correlates ? ? O
of ? ? O
these ? ? O
FCs ? ? I-disease
, ? ? O
we ? ? O
used ? ? O
fos ? ? O
immunohistochemistry ? ? O
and ? ? O
found ? ? O
that ? ? O
animals ? ? O
with ? ? O
FCs ? ? I-disease
had ? ? O
fos-positive ? ? I-disease
immunoreactivity ? ? I-disease
in ? ? O
brain ? ? O
regions ? ? O
involved ? ? O
in ? ? O
seizures ? ? I-disease
. ? ? O

After 15509232 ? O
a ? ? O
period ? ? O
of ? ? O
72 ? ? O
h ? ? O
, ? ? O
we ? ? O
also ? ? O
examined ? ? O
brains ? ? O
for ? ? O
pathologic ? ? O
changes ? ? O
and ? ? O
found ? ? O
no ? ? O
differences ? ? O
among ? ? O
our ? ? O
groups ? ? O
. ? ? O

CONCLUSIONS 15509232 ? O
: ? ? O
Our ? ? O
data ? ? O
indicate ? ? O
that ? ? O
a ? ? O
neuroimmune ? ? O
challenge ? ? O
and ? ? O
its ? ? O
accompanying ? ? O
fever ? ? I-disease
reduce ? ? O
the ? ? O
seizure ? ? I-disease
threshold ? ? O
. ? ? O

Furthermore 15509232 ? O
, ? ? O
the ? ? O
FCs ? ? I-disease
induced ? ? O
by ? ? O
fever ? ? I-disease
in ? ? O
this ? ? O
model ? ? O
do ? ? O
not ? ? O
have ? ? O
short-term ? ? O
adverse ? ? O
effects ? ? O
on ? ? O
the ? ? O
brain ? ? O
. ? ? O

In 15509232 ? O
addition ? ? O
, ? ? O
this ? ? O
model ? ? O
, ? ? O
by ? ? O
incorporating ? ? O
physiologic ? ? O
fever ? ? I-disease
, ? ? O
may ? ? O
be ? ? O
useful ? ? O
for ? ? O
examining ? ? O
the ? ? O
role ? ? O
of ? ? O
fever ? ? I-disease
and ? ? O
its ? ? O
constituent ? ? O
mediators ? ? O
in ? ? O
the ? ? O
genesis ? ? O
of ? ? O
FCs ? ? I-disease
. ? ? O

In 15530052 ? O
situ ? ? O
gelling ? ? O
of ? ? O
alginate ? ? I-treatment
/ ? ? I-treatment
pluronic ? ? I-treatment
solutions ? ? I-treatment
for ? ? O
ophthalmic ? ? O
delivery ? ? O
of ? ? O
pilocarpine ? ? I-treatment
. ? ? O

We 15530052 ? O
prepared ? ? O
a ? ? O
series ? ? O
of ? ? O
alginate ? ? I-treatment
and ? ? O
Pluronic-based ? ? I-treatment
solutions ? ? I-treatment
as ? ? O
the ? ? O
in ? ? O
situ ? ? O
gelling ? ? O
vehicles ? ? O
for ? ? O
ophthalmic ? ? O
delivery ? ? O
of ? ? O
pilocarpine ? ? I-treatment
. ? ? O

The 15530052 ? O
rheological ? ? O
properties ? ? O
, ? ? O
in ? ? O
vitro ? ? O
release ? ? O
as ? ? O
well ? ? O
as ? ? O
in ? ? O
vivo ? ? O
pharmacological ? ? O
response ? ? O
of ? ? O
polymer ? ? O
solutions ? ? O
, ? ? O
including ? ? O
alginate ? ? I-treatment
, ? ? O
Pluronic ? ? I-treatment
solution ? ? I-treatment
, ? ? O
and ? ? O
alginate ? ? I-treatment
/ ? ? I-treatment
Pluronic ? ? I-treatment
solution ? ? I-treatment
, ? ? O
were ? ? O
evaluated ? ? O
. ? ? O

The 15530052 ? O
optimum ? ? O
concentration ? ? O
of ? ? O
alginate ? ? I-treatment
solution ? ? I-treatment
for ? ? O
the ? ? O
in ? ? O
situ ? ? O
gel-forming ? ? O
delivery ? ? O
systems ? ? O
was ? ? O
2 ? ? O
% ? ? O
( ? ? O
w ? ? O
/ ? ? O
w ? ? O
) ? ? O
and ? ? O
that ? ? O
for ? ? O
Pluronic ? ? I-treatment
solution ? ? I-treatment
was ? ? O
14 ? ? O
% ? ? O
( ? ? O
w ? ? O
/ ? ? O
w ? ? O
) ? ? O
. ? ? O

The 15530052 ? O
mixture ? ? O
of ? ? O
0.1 ? ? O
% ? ? O
alginate ? ? I-treatment
and ? ? O
14 ? ? O
% ? ? O
Pluronic ? ? I-treatment
solutions ? ? I-treatment
showed ? ? O
a ? ? O
significant ? ? O
increase ? ? O
in ? ? O
gel ? ? O
strength ? ? O
in ? ? O
the ? ? O
physiological ? ? O
condition ? ? O
; ? ? O
this ? ? O
gel ? ? O
mixture ? ? O
was ? ? O
also ? ? O
found ? ? O
to ? ? O
be ? ? O
free ? ? O
flowing ? ? O
at ? ? O
pH ? ? O
4.0 ? ? O
and ? ? O
25 ? ? O
degrees ? ? O
C. ? ? O
Both ? ? O
in ? ? O
vitro ? ? O
release ? ? O
and ? ? O
in ? ? O
vivo ? ? O
pharmacological ? ? O
studies ? ? O
indicated ? ? O
that ? ? O
the ? ? O
alginate ? ? I-treatment
/ ? ? I-treatment
Pluronic ? ? I-treatment
solution ? ? I-treatment
retained ? ? O
pilocarpine ? ? I-treatment
better ? ? O
than ? ? O
the ? ? O
alginate ? ? I-treatment
or ? ? O
Pluronic ? ? I-treatment
solutions ? ? I-treatment
alone ? ? O
. ? ? O

The 15530052 ? O
results ? ? O
demonstrated ? ? O
that ? ? O
the ? ? O
alginate ? ? I-treatment
/ ? ? I-treatment
Pluronic ? ? I-treatment
mixture ? ? O
can ? ? O
be ? ? O
used ? ? O
as ? ? O
an ? ? O
in ? ? O
situ ? ? O
gelling ? ? O
vehicle ? ? O
to ? ? O
increase ? ? O
ocular ? ? O
bioavailability ? ? O
. ? ? O

[ 26602803 ? O
Experience ? ? O
in ? ? O
molecular ? ? O
diagnostic ? ? O
in ? ? O
hereditary ? ? I-disease
neuropathies ? ? I-disease
in ? ? O
a ? ? O
pediatric ? ? O
tertiary ? ? O
hospital ? ? O
] ? ? O
. ? ? O

INTRODUCTION 26602803 ? O
: ? ? O
Charcot-Marie-Tooth ? ? I-disease
( ? ? O
CMT ? ? I-disease
) ? ? O
is ? ? O
the ? ? O
most ? ? O
common ? ? O
hereditary ? ? I-disease
sensory ? ? I-disease
motor ? ? I-disease
neuropathy ? ? I-disease
. ? ? O

Advances 26602803 ? O
in ? ? O
molecular ? ? O
diagnosis ? ? O
have ? ? O
increased ? ? O
the ? ? O
diagnostic ? ? O
possibilities ? ? O
of ? ? O
these ? ? O
patients ? ? O
. ? ? O

PATIENTS 26602803 ? O
AND ? ? O
METHODS ? ? O
: ? ? O
Retrospective ? ? O
study ? ? O
of ? ? O
36 ? ? O
pediatric ? ? O
patients ? ? O
diagnosed ? ? O
with ? ? O
CMT ? ? I-disease
in ? ? O
a ? ? O
tertiary ? ? O
center ? ? O
in ? ? O
2003-2015 ? ? O
. ? ? O

RESULTS 26602803 ? O
: ? ? O
We ? ? O
found ? ? O
16 ? ? O
patients ? ? O
were ? ? O
diagnosed ? ? O
by ? ? O
a ? ? O
duplication ? ? O
in ? ? O
PMP22 ? ? I-gene
; ? ? O
two ? ? O
cases ? ? O
were ? ? O
diagnosed ? ? O
of ? ? O
hereditary ? ? I-disease
neuropathy ? ? I-disease
with ? ? I-disease
liability ? ? I-disease
to ? ? I-disease
pressure ? ? I-disease
palsies ? ? I-disease
, ? ? O
one ? ? O
with ? ? O
a ? ? O
point ? ? O
mutation ? ? O
in ? ? O
PMP22 ? ? I-gene
; ? ? O
a ? ? O
male ? ? O
with ? ? O
a ? ? O
mild ? ? I-disease
demyelinating ? ? I-disease
phenotype ? ? O
, ? ? O
without ? ? O
family ? ? O
history ? ? O
, ? ? O
was ? ? O
diagnosed ? ? O
with ? ? O
GJB1 ? ? I-gene
mutation ? ? O
; ? ? O
in ? ? O
a ? ? O
patient ? ? O
with ? ? O
a ? ? O
peripheral ? ? I-disease
hypotonia ? ? I-disease
at ? ? O
birth ? ? O
and ? ? O
axonal ? ? I-disease
pattern ? ? I-disease
in ? ? I-disease
EMG ? ? I-disease
by ? ? O
mutation ? ? O
in ? ? O
MFN2 ? ? I-gene
; ? ? O
a ? ? O
gypsy ? ? O
patient ? ? O
, ? ? O
with ? ? O
consanguineous ? ? O
family ? ? O
, ? ? O
CMT4D ? ? I-disease
, ? ? O
was ? ? O
identified ? ? O
by ? ? O
a ? ? O
mutation ? ? O
in ? ? O
the ? ? O
gene ? ? O
NDRG1 ? ? I-gene
; ? ? O
a ? ? O
patient ? ? O
with ? ? O
multiplex ? ? I-disease
congenital ? ? I-disease
arthrogryposis ? ? I-disease
and ? ? O
vocal ? ? I-disease
cord ? ? I-disease
paralysis ? ? I-disease
, ? ? O
whose ? ? O
mother ? ? O
had ? ? O
a ? ? O
scapular-peroneal ? ? I-disease
syndrome ? ? I-disease
, ? ? O
had ? ? O
a ? ? O
congenital ? ? I-disease
spinal ? ? I-disease
muscular ? ? I-disease
atrophy ? ? I-disease
with ? ? O
mild ? ? I-disease
distal ? ? I-disease
axonal ? ? I-disease
neuropathy ? ? I-disease
by ? ? O
mutation ? ? O
in ? ? O
gene ? ? O
TRPV4 ? ? I-gene
; ? ? O
three ? ? O
girls ? ? O
, ? ? O
from ? ? O
a ? ? O
gypsy ? ? O
consanguineous ? ? O
family ? ? O
, ? ? O
with ? ? O
axonal ? ? I-disease
CMT ? ? I-disease
with ? ? I-disease
neuromyotonic ? ? I-disease
discharges ? ? I-disease
were ? ? O
diagnosed ? ? O
by ? ? O
a ? ? O
mutation ? ? O
in ? ? O
the ? ? O
gene ? ? O
HINT1 ? ? I-gene
; ? ? O
twelve ? ? O
patients ? ? O
have ? ? O
n't ? ? O
molecular ? ? O
diagnosis ? ? O
currently ? ? O
. ? ? O

CONCLUSIONS 26602803 ? O
: ? ? O
CMT1A ? ? I-disease
predominated ? ? O
in ? ? O
our ? ? O
series ? ? O
( ? ? O
44 ? ? O
% ? ? O
) ? ? O
, ? ? O
as ? ? O
previous ? ? O
studies ? ? O
. ? ? O

We 26602803 ? O
emphasize ? ? O
the ? ? O
description ? ? O
of ? ? O
a ? ? O
patient ? ? O
with ? ? O
a ? ? O
mutation ? ? O
in ? ? O
TRPV4 ? ? I-gene
recently ? ? O
described ? ? O
as ? ? O
a ? ? O
cause ? ? O
of ? ? O
CMT2C ? ? I-disease
and ? ? O
three ? ? O
cases ? ? O
, ? ? O
of ? ? O
gypsy ? ? O
consanguineous ? ? O
family ? ? O
, ? ? O
with ? ? O
the ? ? O
same ? ? O
mutation ? ? O
in ? ? O
HINT1 ? ? I-gene
gene ? ? O
, ? ? O
recently ? ? O
described ? ? O
as ? ? O
a ? ? O
cause ? ? O
of ? ? O
axonal ? ? I-disease
neuropathy ? ? I-disease
with ? ? I-disease
neuromyotonia ? ? I-disease
, ? ? I-disease
autosomal ? ? I-disease
recessive ? ? I-disease
( ? ? O
AR-CMT2 ? ? I-disease
) ? ? O
. ? ? O

The 26602803 ? O
proportion ? ? O
of ? ? O
patients ? ? O
without ? ? O
molecular ? ? O
diagnosis ? ? O
is ? ? O
similar ? ? O
to ? ? O
main ? ? O
European ? ? O
series ? ? O
. ? ? O

